KIMBERLY WILSON: Open Payments
NPI 1841749439 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 15 payments from 9 companies in 2025. Trend: 2023 $30 · 2024 $219 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $118 |
| ABBVIE INC. | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $18 |
Products named: DEXCOM G7 GSS (161), JARDIANCE, QULIPTA, UBRELVY, AIRSUPRA, MOUNJARO, LINZESS, Veozah.
Industry payments across OK — which companies pay providers there.
